Mannitol
Reduction of intracranial pressure, Treatment of cerebral edema, Reduction of intraocular pressure
Indications
- Reduction of intracranial pressure
- Treatment of cerebral edema
- Reduction of intraocular pressure
Adult dosing
- intracranial pressure: dose: 0.25; unit: g/kg; route: IV; interval: over at least 30 minutes; repeat no more often than every 6 to 8 hours; weightBased: true; labelExcerpt: Usually a maximum reduction in intracranial pressure can be achieved with a dose of 0.25 g/kg
- intraocular pressure: dose: 1.5; unit: g/kg; route: IV; interval: single dose (1.5 to 2 g/kg) over at least 30 minutes; weightBased: true; labelExcerpt: The recommended dosage is 1.5 to 2 g/kg as a single dose administered as an intravenous infusion over at least 30 minutes
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Hypersensitivity to mannitol
- Anuria
- Severe hypovolemia
- Pre-existing pulmonary edema
- Active intracranial bleeding
Clinical pearls
- Use a filter for infusion to prevent crystals.
- Do not administer with blood products due to potential pseudoagglutination.
- Monitor fluid, electrolytes, and renal function closely during and after infusion.
- Warm vials at 80°C to dissolve crystals prior to use.
Source and review
- DailyMed label (mannitol), Set ID e2444db1-9dfe-451f-a33c-9b00786464d2, effective 2026-11-02. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties